Why the Biggest Challenge Isn't Technology It's Translation Every generation faces a defining challenge. For some, it...
Talking Medicines Blogs
Great strategies start with understanding People. Explore our Talking Medicines blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news.
Aligning People, AI and Science: Why Message Measurement Will Define the Next Era of Healthcare Innovation
Why Message Measurement Will Define the Next Era of Healthcare Innovation Artificial Intelligence is accelerating...
Synthetic Personas vs Evidence-Based Personas: Moving from “What They Say” to “What They Do”
The Evolution of Personas For years, personas have supported businesses to humanize their audiences. Traditionally,...
Beyond the Clinical Data: Why Patient, Consumer and HCP Conversations Matter in the Future of GLP-1s and Cancer Care
The Conversation Has Already Started Scientific conferences often spark new healthcare discussions, where healthcare...
GLP-1s Are Breaking Into New Territory: What ASCO 2026 Reveals About Their Potential in Oncology
A New Frontier for GLP-1 Therapies Few therapeutic classes have generated as much attention as GLP-1 therapies in...
GLP-1s Are Redefining More Than Healthcare – They are Reshaping Entire Industries
Healthcare Innovation with Wide Market Effects GLP-1 receptor agonists, initially developed for type 2 diabetes and...
Connected Patient Journeys: How Message Resonance Is Redefining Engagement
Why Patient behavior is reshaping Pharma marketing strategies For years, Pharma marketing has been structured around...
Message Resonance Before Engagement: How Patient Understanding Is Reshaping HCP Conversations
How this builds on connected Patient journeys In our previous blog, we explored how connected Patient journeys and...
Motivation and Behavior: The Influence of GLP-1 Therapies Beyond Metabolic Health
GLP-1: More Than a Metabolic Hormone Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly becoming one...
The GLP-1 Narrative is Splitting: Convenience vs Coverage
The GLP-1 Inflection Point Coming out of industry news this past week are two developments that, on the surface, look...
Talking Medicines and Socialgist Partner to Capture the GLP-1 Consumer Voice from Real-Life Conversations
The GLP-1 consumer shift is clear, but the signals behind it are often hard to see. That’s why we’ve partnered with...
GLP-1s and the Information Explosion: When Consumer Curiosity Meets AI-Driven Health Decisions
The Rise of the Health-Seeking Consumer We are witnessing a fundamental shift: Patients are no longer simply passive...